Charles River Laboratories International (CRL) Depreciation & Amortization (CF) (2009 - 2026)
Charles River Laboratories International (CRL) posted Depreciation & Amortization (CF) of $67.29 million for Q2 2026, down 43.7% from $119.51 million a year earlier but up 0.2% from the prior quarter.
Charles River Laboratories International (CRL) Depreciation & Amortization (CF) (2009 - 2026) Analysis & Trends
For the trailing twelve months through Jun 27, 2026, Depreciation & Amortization (CF) at Charles River Laboratories International was $297.88 million, down 30.8% year-over-year; for FY2025, it was $403.31 million, up 11.5% from FY2024.
- Annual Depreciation & Amortization (CF) has increased for ten consecutive years, with a five-year compound annual growth rate of 11.4% (FY2020 to FY2025).
- In prior years, Charles River Laboratories International's Depreciation & Amortization (CF) was $361.74 million in FY2024 (+15.2%), $314.12 million in FY2023 (+3.4%), $303.87 million in FY2022 (+14.4%) and $265.54 million in FY2021 (+13.0%).
- Quarterly Depreciation & Amortization (CF) has run from a low of $67.15 million in Q1 2026 to a high of $120.36 million in Q1 2025 over five years.
- On a year-over-year basis, Depreciation & Amortization (CF) has declined in each of the last four quarters, with growth averaging 0.5% over the last eight quarters.
- The strongest year-over-year quarter for Depreciation & Amortization (CF) in the past five years was Q1 2025, with growth of 41.0%; the weakest was Q1 2026, with a decline of 44.2%.
- According to Business Quant data, Depreciation & Amortization (CF) for the three prior quarters was $67.15 million (Q1 2026), $78.28 million (Q4 2025) and $85.16 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 43.61 Bn | 35.31 Bn | 1.44 Bn | 292.00 Mn |
| 2 | Medpace Holdings | 17.34 Bn | 15.40 Bn | 201.64 Mn | 6.56 Mn |
| 3 | Charles River Laboratories International | 14.63 Bn | 13.82 Bn | 363.37 Mn | 67.29 Mn |
| 4 | Icon | 13.16 Bn | 10.27 Bn | 479.29 Mn | 90.77 Mn |
| 5 | Fortrea Holdings | 2.02 Bn | 1.40 Bn | 139.20 Mn | 19.60 Mn |
| 6 | Ginkgo Bioworks Holdings | 723.40 Mn | -38.68 Mn | 18.44 Mn | 12.32 Mn |
| 7 | Evotec SE | 502.55 Mn | -1.11 Bn | - | - |
| 8 | Champions Oncology | 66.57 Mn | 41.65 Mn | 7.70 Mn | 314,000.00 |
| 9 | MindWalk Holdings | 63.08 Mn | 26.73 Mn | 1.61 Mn | 190,775.50 |
| 10 | Natural Alternatives International | 6.81 Mn | -21.27 Mn | 1.73 Mn | 1.18 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 27, 2026 | 67.29 Mn |
| Mar 28, 2026 | 67.15 Mn |
| Dec 27, 2025 | 78.28 Mn |
| Sep 27, 2025 | 85.16 Mn |
| Jun 28, 2025 | 119.51 Mn |
| Mar 29, 2025 | 120.36 Mn |
| Dec 28, 2024 | 102.10 Mn |
| Sep 28, 2024 | 88.20 Mn |
| Jun 29, 2024 | 86.08 Mn |
| Mar 30, 2024 | 85.36 Mn |
| Dec 30, 2023 | 80.51 Mn |
| Sep 30, 2023 | 78.87 Mn |
| Jul 1, 2023 | 77.67 Mn |
| Apr 1, 2023 | 77.07 Mn |
| Dec 31, 2022 | 77.55 Mn |
| Sep 24, 2022 | 74.61 Mn |
| Jun 25, 2022 | 76.42 Mn |
| Mar 26, 2022 | 75.30 Mn |
| Dec 25, 2021 | 67.24 Mn |
| Sep 25, 2021 | 68.69 Mn |
Charles River Laboratories International Depreciation & Amortization (CF) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=CRL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "depreciation-and-amortization-cf", "ticker": "CRL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=CRL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();